Abstract: An agricultural modeling system may include a mobile LiDAR platform configured to generate 3D point cloud data of an agricultural geographic area, client devices, a geospatial database configured to store a data layer for the agricultural geographic area, and a server computing resource in communication with the mobile LiDAR platform, the client devices, and the geospatial database. The server computing resource may be configured to geographically reference the data layer fused with the 3D point cloud data of the agricultural geographic area, and generate a multi-layered data model for the geographically referenced data layer fused with the 3D point cloud data of the agricultural geographic area for providing interactive analysis and visualization of agricultural information alongside collaborators with LiDAR-based high resolution 3D plant model. A client device may be configured to selectively render the multi-layered data model.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The invention relates to inhibitory anti-factor XII/FXIla antibodies and methods of their use.

Abstract: A device remotely supporting an implantable cardiac device is disclosed. The device includes at least one video input configured to receive at least a video signal from a programmer for an implantable cardiac device, at least one audio input, a network interface, a display, and a user input. The device may also include one or more hardware processors configured with instructions to transmit one or more video signals received at the at least one video input over a network to a remote location via the network interface, transmit one or more audio signals received at the at least one audio input over the network to the remote location via the network interface, receive patient data from a database on the network via the network interface, and display the patient data on the display.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor ? (IL-3R?) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: A computer system and associated methods for verifying user identities online. Identity claims made by a requestor of an online access and/or a trusted transaction may be verified by associating digital credentials to verified personal identification information (PII) retrieved from real world events. PII item(s) may be retrieved from third-party verified identity information sources. Verified personal attributes related to PII items may be identified and correlated with the requestor's digital credentials, and stored to a verified identity record. Additional digital credentials for the same requestor may be similarly identified, correlated, and stored to the verified identity record. A subsequent transaction request by a person claiming the requestor's identity may be compared with the verified identity record. An identity match indicator and/or a match confidence score may be created and used to determine the risk that the identity claim by the person requesting the transaction is false.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: A computer system and associated methods for verifying user identities online. Identity claims made by a requestor of an online access and/or a trusted transaction may be verified by associating digital credentials to verified personal identification information (PII) retrieved from real world events. PII item(s) may be retrieved from third-party verified identity information sources. Verified personal attributes related to PII items may be identified and correlated with the requestor's digital credentials, and stored to a verified identity record. Additional digital credentials for the same requestor may be similarly identified, correlated, and stored to the verified identity record. A subsequent transaction request by a person claiming the requestor's identity may be compared with the verified identity record. An identity match indicator and/or a match confidence score may be created and used to determine the risk that the identity claim by the person requesting the transaction is false.

Abstract: The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor ? (IL-3R?) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.

Abstract: The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.

Abstract: The present invention relates generally to the field of cancer therapy and prophylaxis. More particularly, the present invention provides growth factor antagonists which inhibit the growth of cancers including tumors and pre-cancerous tissue. Even more particularly, the present invention is directed to antagonists of vascular endothelial growth factor-B and their use to inhibit the growth of cancer including tumor tissue and pre-cancerous tissue.

Abstract: The invention relates to inhibitory anti-factor XII/FXIIa antibodies and methods of their use.

Abstract: The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor ? (IL-3R?) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.

Abstract: The present disclosure provides a method for treating lupus, Sjörgen's syndrome or scleroderma, the method comprising administering to the mammal an immunoglobulin which binds an interleukin 3 receptor ? (IL-3R?) chain and which depletes or at least partly eliminates plasmacytoid dendritic cells (p DCs) and basophils to which it binds.